The product approval for Bactiguard’s urinary (Foley) catheters has been announced by the Egyptian Ministry of Health. This opens new opportunities for Bactiguard in providing effective infection prevention in the most populous country in North Africa and the Middle East.
“We are finally through the registration process in Egypt, which started more than an year ago and was longer than expected. This is a breakthrough and together with our distributor Heal Pharma, we can now start the launch activities in the most populous country in the region”, says Jonas Östregård, SVP Sales and continues:
“Most countries are facing challenges in the healthcare sector including hospital acquired infections and there is an growing need for preventive solutions. With Bactiguard’s portfolio for infection protection, starting with the BIP Foley Catheter, we are convinced that Egypt will be able to reduce infections and limit the use of antibiotics and become one of our biggest markets in the region in a few years.”
Egypt is the most populous country in North Africa and the Middle East, with a population of more than 90 million people. Heal Pharma, based in Cairo, has a nationwide reach and was established in 2008 by Dr Mohamed Khalifa.
For further information, please contact:
Cecilia Edström, CFO mobile: +46 72 226 23 28
